Table 2.
Characteristics of studies included in the meta-analysis.
| Studies | Study design | Stroke duration (Mean ±SD) | Gender (Male/Female) |
Side of effect (Left/Right) |
Intensity, frequency and pulse length | Stimulation location | Direction of effects (+ positive, - negative, +/- both) |
|---|---|---|---|---|---|---|---|
| Chen et al. (15) | Clinical Trial | ≥6 months | 14/8 | 15/7 | 80%AMT, 50Hz/5Hz, 600 pluses | M1 | +/- |
| Liao et al. (32) | Clinical Trial | 10 days- 1 year | 35/8 | 26/17 | 100%RMT, 50Hz/5Hz, 600 pluses | M1 | +/- |
| Sung et al. (16) | Randomized Controlled Trial | 3 months- 12 months, 8.2 ± 1.6 months | 20/6 | - | 80%AMT, 50Hz/5Hz, 600 pluses | M1 | +/- |
| Hsu et al. (17) | Randomized Controlled Trial | 2 weeks- 4 weeks, 21.4 ± 4.5 days | 8/4 | 8/4 | 80%AMT, 50Hz/5Hz, pluses | M1 | +/- |
| Tang et al. (26) | Clinical Trial | 1month-6months, 52.25 ± 24.03 days | 14/2 | 14/2 | 70%RMT, 50Hz/5Hz, 600 pluses | M1 | +/- |
| Yu et al. (27) | Clinical Trial | 15 days- 6 months, 77.93 ± 45.15 days | 24/5 | 12/17 | 70%RMT, 50Hz/5Hz, 600 pluses | M1 | +/- |
| Chen et al. (18) | Randomized Controlled Trial | 2 weeks- 6 months, 90.82 ± 44.67 days | 25/7 | 19/13 | 80%AMT, 50Hz/5Hz, 600 pluses | Cerebellar | +/- |
| Ding et al. (30) | Clinical Trial | ≤ 18months, 3.95 ± 3.7 months | 21/9 | 18/12 | 70%RMT, 50Hz/5Hz, 600 pluses | M1 | +/- |
| Talelli et al. (21) | Clinical Trial | ≥1 year, 27.58 ± 30.11 months | 16/9 | 10/15 | 80%AMT,50Hz/5Hz, 600 pluses | M1 | +/- |
| Zhou et al. (23) | Clinical Trial | 2 weeks-1 month, 27.09 ± 3.34 days | 11/1 | 4/8 | 80%AMT,50Hz/5Hz, 600 pluses | M1 | + |